Adage Capital Partners’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.14M | Buy |
+56,894
| New | +$5.22M | 0.01% | 772 |
|
|
2025
Q2 | – | Sell |
-37,239
| Closed | -$4.21M | – | 965 |
|
|
2025
Q1 | $4.21M | Buy |
+37,239
| New | +$3.98M | 0.01% | 718 |
|
|
2024
Q1 | – | Sell |
-203,042
| Closed | -$24.7M | – | 960 |
|
|
2023
Q4 | $24.7M | Sell |
203,042
-4,700
| -2% | -$524K | 0.05% | 364 |
|
|
2023
Q3 | $23.3M | Buy |
207,742
+34,900
| +20% | +$4.43M | 0.05% | 350 |
|
|
2023
Q2 | $25.2M | Sell |
172,842
-161,570
| -48% | -$22M | 0.05% | 349 |
|
|
2023
Q1 | $43.2M | Buy |
334,412
+120,970
| +57% | +$15.2M | 0.1% | 248 |
|
|
2022
Q4 | $27.2M | Buy |
213,442
+124,700
| +141% | +$14.5M | 0.07% | 339 |
|
|
2022
Q3 | $9.28M | Sell |
88,742
-129,500
| -59% | -$14.2M | 0.02% | 661 |
|
|
2022
Q2 | $22.9M | Buy |
218,242
+130,100
| +148% | +$15.4M | 0.05% | 383 |
|
|
2022
Q1 | $11.3M | Sell |
88,142
-141,179
| -62% | -$17M | 0.02% | 661 |
|
|
2021
Q4 | $28.3M | Buy |
229,321
+72,924
| +47% | +$9.54M | 0.05% | 361 |
|
|
2021
Q3 | $22.2M | Sell |
156,397
-75,396
| -33% | -$11.1M | 0.04% | 414 |
|
|
2021
Q2 | $36.2M | Sell |
231,793
-5,562
| -2% | -$901K | 0.07% | 287 |
|
|
2021
Q1 | $36.9M | Buy |
237,355
+73,439
| +45% | +$11.4M | 0.08% | 283 |
|
|
2020
Q4 | $24.5M | Buy |
163,916
+46,350
| +39% | +$6.55M | 0.05% | 362 |
|
|
2020
Q3 | $15.5M | Sell |
117,566
-129,265
| -52% | -$16.9M | 0.04% | 436 |
|
|
2020
Q2 | $28.6M | Buy |
246,831
+5,287
| +2% | +$609K | 0.07% | 301 |
|
|
2020
Q1 | $23.7M | Sell |
241,544
-5,459
| -2% | -$716K | 0.07% | 288 |
|
|
2019
Q4 | $35.9M | Sell |
247,003
-10,300
| -4% | -$1.42M | 0.09% | 264 |
|
|
2019
Q3 | $34.3M | Buy |
257,303
+1,299
| +0.5% | +$168K | 0.08% | 264 |
|
|
2019
Q2 | $29.3M | Sell |
256,004
-265,665
| -51% | -$31.1M | 0.07% | 293 |
|
|
2019
Q1 | $64.7M | Buy |
521,669
+159,307
| +44% | +$18.1M | 0.16% | 159 |
|
|
2018
Q4 | $36.5M | Buy |
362,362
+91,963
| +34% | +$10.3M | 0.1% | 225 |
|
|
2018
Q3 | $34.5M | Buy |
270,399
+212,096
| +364% | +$25.2M | 0.08% | 291 |
|
|
2018
Q2 | $6.31M | Sell |
58,303
-372,994
| -86% | -$40.6M | 0.01% | 630 |
|
|
2018
Q1 | $45.7M | Buy |
431,297
+217,227
| +101% | +$25.2M | 0.11% | 238 |
|
|
2017
Q4 | $25.1M | Buy |
214,070
+123,188
| +136% | +$13.9M | 0.06% | 347 |
|
|
2017
Q3 | $10.3M | Sell |
90,882
-307,115
| -77% | -$35.5M | 0.03% | 551 |
|
|
2017
Q2 | $49.6M | Buy |
397,997
+127,720
| +47% | +$15.1M | 0.12% | 222 |
|
|
2017
Q1 | $32M | Sell |
270,277
-77,456
| -22% | -$8.78M | 0.08% | 310 |
|
|
2016
Q4 | $34.8M | Sell |
347,733
-374,817
| -52% | -$40.2M | 0.1% | 265 |
|
|
2016
Q3 | $91.2M | Sell |
722,550
-218,360
| -23% | -$27M | 0.25% | 108 |
|
|
2016
Q2 | $110M | Buy |
940,910
+20,085
| +2% | +$2.27M | 0.3% | 92 |
|
|
2016
Q1 | $95.3M | Buy |
920,825
+245,250
| +36% | +$23.7M | 0.26% | 114 |
|
|
2015
Q4 | $67.3M | Buy |
675,575
+567,221
| +523% | +$55.5M | 0.18% | 156 |
|
|
2015
Q3 | $9.88M | Buy |
+108,354
| New | +$10.9M | 0.03% | 537 |
|
|
2015
Q2 | – | Sell |
-13,110
| Closed | -$1.5M | – | 770 |
|
|
2015
Q1 | $1.5M | Sell |
13,110
-628,094
| -98% | -$71.7M | ﹤0.01% | 678 |
|
|
2014
Q4 | $70.6M | Sell |
641,204
-241,535
| -27% | -$25.5M | 0.17% | 159 |
|
|
2014
Q3 | $86.2M | Buy |
882,739
+178,499
| +25% | +$17.6M | 0.21% | 125 |
|
|
2014
Q2 | $71M | Buy |
704,240
+657,037
| +1,392% | +$64.1M | 0.18% | 156 |
|
|
2014
Q1 | $4.33M | Sell |
47,203
-113,609
| -71% | -$10.5M | 0.01% | 604 |
|
|
2013
Q4 | $14.6M | Buy |
160,812
+157,207
| +4,361% | +$13.6M | 0.04% | 458 |
|
|
2013
Q3 | $287K | Sell |
3,605
-64,890
| -95% | -$5.11M | ﹤0.01% | 675 |
|
|
2013
Q2 | $4.98M | Buy |
+68,495
| New | +$5.12M | 0.02% | 592 |
|
Other funds holding ZBH
VCM
VPM
Adage Capital Partners's ZBH Position: Q1 2026 in Review
Adage Capital Partners opened a new position in Zimmer Biomet (ZBH) in Q1 2026: 56,894 shares worth $5.14M. The stake represents 0.01% of the portfolio and ranks #772 among its holdings. This is a return to the name: Adage Capital Partners previously reported a position in ZBH as recently as Q1 2025.
Adage Capital Partners first reported a position in ZBH in Q2 2013 and has held it in 44 quarters since. The position peaked at $110M in Q2 2016. 913 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Adage Capital Partners held 56,894 shares of Zimmer Biomet worth $5.14M as of Q1 2026.
- Zimmer Biomet was a new Adage Capital Partners position in Q1 2026.
- Zimmer Biomet made up 0.01% of Adage Capital Partners's portfolio in Q1 2026, its #772 holding.
- Adage Capital Partners first reported a position in Zimmer Biomet in Q2 2013 and has held it in 44 quarters since.
- Adage Capital Partners's Zimmer Biomet position peaked at $110M in Q2 2016.
- 913 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.